Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 425

1.

A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin.

Clark A, Kuo MC, Newman S, Hirst P, Pitcairn G, Pickford M.

Pharm Res. 2008 Jul;25(7):1583-90. doi: 10.1007/s11095-008-9547-x. Epub 2008 Feb 21.

PMID:
18288448
2.

Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.

Sham JO, Zhang Y, Finlay WH, Roa WH, Löbenberg R.

Int J Pharm. 2004 Jan 28;269(2):457-67.

PMID:
14706257
3.

Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.

Glover W, Chan HK, Eberl S, Daviskas E, Verschuer J.

Int J Pharm. 2008 Feb 12;349(1-2):314-22. Epub 2007 Aug 19.

PMID:
17904774
4.

Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhaler.

Rohatagi S, Chapel S, Kirkesseli S, Newman S, Zhang J, Paccaly D, Randall L, Wray H, Wellington S, Shah B, Jensen BK.

Am J Ther. 2004 Mar-Apr;11(2):103-13.

PMID:
14999362
5.

Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.

Martin GP, Marriott C, Zeng XM.

Pharm Res. 2007 Feb;24(2):361-9. Epub 2006 Dec 20.

PMID:
17177114
6.
7.
8.

Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.

Chan HK, Clark A, Gonda I, Mumenthaler M, Hsu C.

Pharm Res. 1997 Apr;14(4):431-7.

PMID:
9144727
9.

Effect of additives on insulin absorption from intratracheally administered dry powders in rats.

Todo H, Okamoto H, Iida K, Danjo K.

Int J Pharm. 2001 Jun 4;220(1-2):101-10.

PMID:
11376972
10.

Development and testing of particulate formulations for the nasal delivery of antibodies.

Kaye RS, Purewal TS, Alpar OH.

J Control Release. 2009 Apr 17;135(2):127-35. doi: 10.1016/j.jconrel.2008.11.009. Epub 2008 Nov 24.

PMID:
19059291
11.

Promising ternary dry powder inhaler formulations of cromolyn sodium: formulation and in vitro-in vivo evaluation.

Elbary AA, El-laithy HM, Tadros MI.

Arch Pharm Res. 2007 Jun;30(6):785-92.

PMID:
17679559
12.

Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.

Sinsuebpol C, Chatchawalsaisin J, Kulvanich P.

Drug Des Devel Ther. 2013 Aug 28;7:861-73. doi: 10.2147/DDDT.S47681. eCollection 2013.

13.

Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.

Marriott C, MacRitchie HB, Zeng XM, Martin GP.

Int J Pharm. 2006 Dec 1;326(1-2):39-49. Epub 2006 Jul 16.

PMID:
16942848
14.

Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats.

Kobayashi S, Kondo S, Juni K.

Pharm Res. 1996 Jan;13(1):80-3.

PMID:
8668684
15.

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.

Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH.

Int J Pharm. 2005 Nov 23;305(1-2):180-5. Epub 2005 Oct 19.

PMID:
16242277
16.

[Study on pulmonary delivery system of salmon calcitonin in rats].

Wang Z, Zhang Q.

Beijing Da Xue Xue Bao. 2003 Jun 18;35(3):329-32. Chinese.

17.
18.

Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size.

Esposito-Festen JE, Zanen P, Tiddens HA, Lammers JW.

Br J Clin Pharmacol. 2007 Sep;64(3):328-34. Epub 2007 Apr 18.

19.

Bioavailability of intranasal formulations of dihydroergotamine.

van der Kuy PH, Lohman JJ, Hooymans PM, Ter Berg JW, Merkus FW.

Eur J Clin Pharmacol. 1999 Nov;55(9):677-80.

PMID:
10638398
20.

Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.

Pilcer G, Vanderbist F, Amighi K.

Int J Pharm. 2009 Jan 5;365(1-2):162-9. doi: 10.1016/j.ijpharm.2008.08.014. Epub 2008 Aug 22.

PMID:
18782609
Items per page

Supplemental Content

Write to the Help Desk